{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:14:54Z","timestamp":1788261294991,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10633-024-09987-6","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:02:00Z","timestamp":1723647720000},"page":"63-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl"],"prefix":"10.1007","volume":"149","author":[{"given":"A.","family":"Amato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Tschetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. T.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4943-6599","authenticated-orcid":false,"given":"M. E.","family":"Pennesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"issue":"3","key":"9987_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cell.2005.06.042","volume":"122","author":"M Jin","year":"2005","unstructured":"Jin M, Li S, Moghrabi WN, Sun H, Travis GH (2005) Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 122(3):449\u2013459","journal-title":"Cell"},{"issue":"35","key":"9987_CR2","doi-asserted-by":"publisher","first-page":"12413","DOI":"10.1073\/pnas.0503460102","volume":"102","author":"G Moiseyev","year":"2005","unstructured":"Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX (2005) RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci U S A 102(35):12413\u201312418","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"9987_CR3","doi-asserted-by":"publisher","first-page":"13658","DOI":"10.1073\/pnas.0504167102","volume":"102","author":"TM Redmond","year":"2005","unstructured":"Redmond TM, Poliakov E, Yu S, Tsai JY, Lu Z, Gentleman S (2005) Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc Natl Acad Sci U S A 102(38):13658\u201313663","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9987_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.exer.2010.08.013","volume":"91","author":"RO Parker","year":"2010","unstructured":"Parker RO, Crouch RK (2010) Retinol dehydrogenases (RDHs) in the visual cycle. Exp Eye Res 91(6):788\u2013792","journal-title":"Exp Eye Res"},{"issue":"2","key":"9987_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ymthe.2020.11.029","volume":"29","author":"AM Maguire","year":"2021","unstructured":"Maguire AM, Bennett J, Aleman EM, Leroy BP, Aleman TS (2021) Clinical perspective: treating rpe65-associated retinal dystrophy. Mol Ther 29(2):442\u2013463","journal-title":"Mol Ther"},{"issue":"6","key":"9987_CR6","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","volume":"12","author":"GM Acland","year":"2005","unstructured":"Acland GM, Aguirre GD, Bennett J et al (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12(6):1072\u20131082","journal-title":"Mol Ther"},{"issue":"1","key":"9987_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ng0501-92","volume":"28","author":"GM Acland","year":"2001","unstructured":"Acland GM, Aguirre GD, Ray J et al (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28(1):92\u201395","journal-title":"Nat Genet"},{"issue":"8","key":"9987_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/hum.2006.17.845","volume":"17","author":"SG Jacobson","year":"2006","unstructured":"Jacobson SG, Boye SL, Aleman TS et al (2006) Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in leber congenital amaurosis. Hum Gene Ther 17(8):845\u2013858","journal-title":"Hum Gene Ther"},{"key":"9987_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1479-0556-2-3","volume":"2","author":"CM Lai","year":"2004","unstructured":"Lai CM, Yu MJ, Brankov M et al (2004) Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65(-\/-) knockout mouse eye results in limited rescue. Genet Vaccines Ther 2:3","journal-title":"Genet Vaccines Ther"},{"issue":"21","key":"9987_CR10","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"JW Bainbridge","year":"2008","unstructured":"Bainbridge JW, Smith AJ, Barker SS et al (2008) Effect of gene therapy on visual function in leber\u2019s congenital amaurosis. N Engl J Med 358(21):2231\u20132239","journal-title":"N Engl J Med"},{"issue":"10","key":"9987_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1089\/hum.2008.107","volume":"19","author":"WW Hauswirth","year":"2008","unstructured":"Hauswirth WW, Aleman TS, Kaushal S et al (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19(10):979\u2013990","journal-title":"Hum Gene Ther"},{"issue":"21","key":"9987_CR12","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, Simonelli F, Pierce EA et al (2008) Safety and efficacy of gene transfer for leber\u2019s congenital amaurosis. N Engl J Med 358(21):2240\u20132248","journal-title":"N Engl J Med"},{"issue":"10097","key":"9987_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA et al (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390(10097):849\u2013860","journal-title":"Lancet"},{"key":"9987_CR14","doi-asserted-by":"publisher","first-page":"750586","DOI":"10.3389\/fmed.2021.750586","volume":"8","author":"A Amato","year":"2021","unstructured":"Amato A, Arrigo A, Aragona E et al (2021) Gene therapy in inherited retinal diseases: an update on current state of the art. Front Med (Lausanne) 8:750586","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"9987_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/hum.2013.146","volume":"24","author":"MJ Annear","year":"2013","unstructured":"Annear MJ, Mowat FM, Bartoe JT et al (2013) Successful gene therapy in older Rpe65-deficient dogs following subretinal injection of an adeno-associated vector expressing RPE65. Hum Gene Ther 24(10):883\u2013893","journal-title":"Hum Gene Ther"},{"issue":"7","key":"9987_CR16","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ophtha.2016.03.003","volume":"123","author":"RG Weleber","year":"2016","unstructured":"Weleber RG, Pennesi ME, Wilson DJ et al (2016) Results at 2 years after gene therapy for rpe65-deficient leber congenital amaurosis and severe early-childhood-onset retinal dystrophy. Ophthalmology 123(7):1606\u20131620","journal-title":"Ophthalmology"},{"issue":"1","key":"9987_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/biomedicines11010103","volume":"11","author":"MJ Gerhardt","year":"2022","unstructured":"Gerhardt MJ, Priglinger CS, Rudolph G et al (2022) Gene therapy with voretigene neparvovec improves vision and partially restores electrophysiological function in pre-school children with leber congenital amaurosis. Biomedicines 11(1):103","journal-title":"Biomedicines"},{"issue":"3","key":"9987_CR18","first-page":"392","volume":"20","author":"RG Weleber","year":"1981","unstructured":"Weleber RG (1981) The effect of age on human cone and rod ganzfeld electroretinograms. Invest Ophthalmol Vis Sci 20(3):392\u2013399","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1\u20132","key":"9987_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ymgme.2004.06.019","volume":"83","author":"RG Weleber","year":"2004","unstructured":"Weleber RG, Gupta N, Trzupek KM, Wepner MS, Kurz DE, Milam AH (2004) Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease). Mol Genet Metab 83(1\u20132):128\u2013137","journal-title":"Mol Genet Metab"},{"issue":"1","key":"9987_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG et al (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1\u201312","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"9987_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson AG, Frishman LJ, Grigg J et al (2022) ISCEV standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144(3):165\u2013177","journal-title":"Doc Ophthalmol"},{"issue":"4","key":"9987_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/tvst.12.4.17","volume":"12","author":"CA Ku","year":"2023","unstructured":"Ku CA, Igelman AD, Huang SJ et al (2023) Improved rod sensitivity as assessed by two-color dark-adapted perimetry in patients with rpe65-related retinopathy treated with voretigene neparvovec-rzyl. Transl Vis Sci Technol 12(4):17","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"9987_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1460-9592.2010.03462.x","volume":"21","author":"K Lalwani","year":"2011","unstructured":"Lalwani K, Tompkins BD, Burnes K, Krahmer MR, Pennesi ME, Weleber RG (2011) The dark side of sedation: 12 years of office-based pediatric deep sedation for electroretinography in the dark. Paediatr Anaesth 21(1):65\u201371","journal-title":"Paediatr Anaesth"},{"issue":"4","key":"9987_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1755-3768.1993.tb04624.x","volume":"71","author":"S Andreasson","year":"1993","unstructured":"Andreasson S, Tornqvist K, Ehinger B (1993) Full-field electroretinograms during general anesthesia in normal children compared to examination with topical anesthesia. Acta Ophthalmol (Copenh) 71(4):491\u2013495","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"6","key":"9987_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/00003246-200206000-00010","volume":"30","author":"A Vardi","year":"2002","unstructured":"Vardi A, Salem Y, Padeh S, Paret G, Barzilay Z (2002) Is propofol safe for procedural sedation in children? A prospective evaluation of propofol versus ketamine in pediatric critical care. Crit Care Med 30(6):1231\u20131236","journal-title":"Crit Care Med"},{"issue":"1","key":"9987_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/cells10010115","volume":"10","author":"MJ Annear","year":"2021","unstructured":"Annear MJ, Mowat FM, Occelli LM et al (2021) A comprehensive study of the retinal phenotype of rpe65-deficient dogs. Cells 10(1):115","journal-title":"Cells"},{"key":"9987_CR27","first-page":"152","volume":"11","author":"JJ Pang","year":"2005","unstructured":"Pang JJ, Chang B, Hawes NL et al (2005) Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human leber congenital amaurosis (LCA). Mol Vis 11:152\u2013162","journal-title":"Mol Vis"},{"issue":"1","key":"9987_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1167\/iovs.02-0567","volume":"44","author":"B Rohrer","year":"2003","unstructured":"Rohrer B, Goletz P, Znoiko S et al (2003) Correlation of regenerable opsin with rod ERG signal in Rpe65-\/-mice during development and aging. Invest Ophthalmol Vis Sci 44(1):310\u2013315","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"9987_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","volume":"29","author":"AV Cideciyan","year":"2010","unstructured":"Cideciyan AV (2010) Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res 29(5):398\u2013427","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"9987_CR30","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1167\/iovs.08-2696","volume":"50","author":"SG Jacobson","year":"2009","unstructured":"Jacobson SG, Aleman TS, Cideciyan AV et al (2009) Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci 50(5):2368\u20132375","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"9987_CR31","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","volume":"372","author":"JW Bainbridge","year":"2015","unstructured":"Bainbridge JW, Mehat MS, Sundaram V et al (2015) Long-term effect of gene therapy on leber\u2019s congenital amaurosis. N Engl J Med 372(20):1887\u20131897","journal-title":"N Engl J Med"},{"issue":"39","key":"9987_CR32","doi-asserted-by":"publisher","first-page":"15112","DOI":"10.1073\/pnas.0807027105","volume":"105","author":"AV Cideciyan","year":"2008","unstructured":"Cideciyan AV, Aleman TS, Boye SL et al (2008) Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A 105(39):15112\u201315117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"9987_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1017\/S0952523800175029","volume":"17","author":"AV Cideciyan","year":"2000","unstructured":"Cideciyan AV, Haeseleer F, Fariss RN et al (2000) Rod and cone visual cycle consequences of a null mutation in the 11-cis-retinol dehydrogenase gene in man. Vis Neurosci 17(5):667\u2013678","journal-title":"Vis Neurosci"},{"issue":"10","key":"9987_CR34","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1371\/journal.pmed.0030347","volume":"3","author":"AP Bemelmans","year":"2006","unstructured":"Bemelmans AP, Kostic C, Crippa SV et al (2006) Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of leber congenital amaurosis. PLoS Med 3(10):e347","journal-title":"PLoS Med"},{"issue":"3","key":"9987_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/sj.mt.6300389","volume":"16","author":"J Bennicelli","year":"2008","unstructured":"Bennicelli J, Wright JF, Komaromy A et al (2008) Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol Ther 16(3):458\u2013465","journal-title":"Mol Ther"},{"issue":"17","key":"9987_CR36","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1073\/pnas.0500646102","volume":"102","author":"SG Jacobson","year":"2005","unstructured":"Jacobson SG, Aleman TS, Cideciyan AV et al (2005) Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci U S A 102(17):6177\u20136182","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"9987_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/gt.2012.63","volume":"20","author":"FM Mowat","year":"2013","unstructured":"Mowat FM, Breuwer AR, Bartoe JT et al (2013) RPE65 gene therapy slows cone loss in Rpe65-deficient dogs. Gene Ther 20(5):545\u2013555","journal-title":"Gene Ther"},{"issue":"6","key":"9987_CR38","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1172\/JCI57377","volume":"121","author":"M Ashtari","year":"2011","unstructured":"Ashtari M, Cyckowski LL, Monroe JF et al (2011) The human visual cortex responds to gene therapy-mediated recovery of retinal function. J Clin Invest 121(6):2160\u20132168","journal-title":"J Clin Invest"},{"issue":"296","key":"9987_CR39","doi-asserted-by":"publisher","first-page":"296ra110","DOI":"10.1126\/scitranslmed.aaa8791","volume":"7","author":"M Ashtari","year":"2015","unstructured":"Ashtari M, Zhang H, Cook PA et al (2015) Plasticity of the human visual system after retinal gene therapy in patients with leber\u2019s congenital amaurosis. Sci Transl Med 7(296):296ra110","journal-title":"Sci Transl Med"},{"issue":"120","key":"9987_CR40","doi-asserted-by":"publisher","first-page":"120ra115","DOI":"10.1126\/scitranslmed.3002865","volume":"4","author":"J Bennett","year":"2012","unstructured":"Bennett J, Ashtari M, Wellman J et al (2012) AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med. 4(120):120ra115","journal-title":"Sci Transl Med."},{"issue":"9701","key":"9987_CR41","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","volume":"374","author":"AM Maguire","year":"2009","unstructured":"Maguire AM, High KA, Auricchio A et al (2009) Age-dependent effects of RPE65 gene therapy for leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial. Lancet 374(9701):1597\u20131605","journal-title":"Lancet"},{"issue":"6","key":"9987_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ophtha.2012.11.048","volume":"120","author":"F Testa","year":"2013","unstructured":"Testa F, Maguire AM, Rossi S et al (2013) Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with leber congenital amaurosis type 2. Ophthalmology 120(6):1283\u20131291","journal-title":"Ophthalmology"},{"key":"9987_CR43","first-page":"2209","volume":"15","author":"MA Cameron","year":"2009","unstructured":"Cameron MA, Lucas RJ (2009) Influence of the rod photoresponse on light adaptation and circadian rhythmicity in the cone ERG. Mol Vis 15:2209\u20132216","journal-title":"Mol Vis"},{"issue":"4496","key":"9987_CR44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1126\/science.7221568","volume":"212","author":"MA Sandberg","year":"1981","unstructured":"Sandberg MA, Berson EL, Effron M (1981) Rod-cone interaction in the distal human retina. Science 212(4496):829\u2013831","journal-title":"Science"},{"issue":"7","key":"9987_CR45","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0042-6989(87)90025-3","volume":"27","author":"DG Birch","year":"1987","unstructured":"Birch DG, Sandberg MA (1987) Dependence of cone b-wave implicit time on rod amplitude in retinitis pigmentosa. Vision Res 27(7):1105\u20131112","journal-title":"Vision Res"},{"issue":"4","key":"9987_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/BF00154382","volume":"80","author":"N Wali","year":"1992","unstructured":"Wali N, Leguire LE (1992) The photopic hill: a new phenomenon of the light adapted electroretinogram. Doc Ophthalmol 80(4):335\u2013345","journal-title":"Doc Ophthalmol"},{"issue":"Pt 1","key":"9987_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/eye.1993.36","volume":"7","author":"L Esakowitz","year":"1993","unstructured":"Esakowitz L, Kriss A, Shawkat F (1993) A comparison of flash electroretinograms recorded from Burian Allen, JET, C-glide, gold foil. DTL and skin electrodes Eye (Lond) 7(Pt 1):169\u2013171","journal-title":"DTL and skin electrodes Eye (Lond)"},{"issue":"8","key":"9987_CR48","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/00006982-200512000-00010","volume":"25","author":"GA Fishman","year":"2005","unstructured":"Fishman GA, Chappelow AV, Anderson RJ, Rotenstreich Y, Derlacki DJ (2005) Short-term inter-visit variability of erg amplitudes in normal subjects and patients with retinitis pigmentosa. Retina 25(8):1014\u20131021","journal-title":"Retina"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-024-09987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-024-09987-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-024-09987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:12:29Z","timestamp":1727723549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-024-09987-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["9987"],"URL":"https:\/\/doi.org\/10.1007\/s10633-024-09987-6","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"16 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (name of institute\/committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures performed in this study involving human participants were done in accordance with the ethical standards of the institutional and national research committee and the Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements of human rights"}},{"value":"This article does not contain any animal experiment.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}},{"value":"The patients consented to participate in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}